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ABSTRACT 
The ability of Clostridium difficile to form highly resilient spores which can survive in the 
environment for prolonged periods causes major contamination problems.  Antimicrobial 405nm 
light is being developed for environmental decontamination within hospitals, however further 
information relating to its sporicidal efficacy is required. This study aims to establish the efficacy of 
405nm light for inactivation of C. difficile vegetative cells and spores, and to establish whether spore 
susceptibility can be enhanced by the combined use of 405nm light with low concentration 
chlorinated disinfectants. Vegetative cells and spore suspensions were exposed to increasing doses 
of 405nm light (at 70-225 mW/cm2) to establish sensitivity. A 99.9% reduction in vegetative cell 
population was demonstrated with a dose of 252 J/cm2, however spores demonstrated higher 
resilience, with a 10-fold increase in required dose. Exposures were repeated with spores suspended 
in the hospital disinfectants sodium hypochlorite, Actichlor and Tristel at non-lethal concentrations 
(0.1%, 0.001% and 0.0001%, respectively). Enhanced sporicidal activity was achieved when spores 
were exposed to 405nm light in the presence of the disinfectants, with a 99.9% reduction achieved 
following exposure to 33% less light dose than required when exposed to 405nm light alone. In 
conclusion, C. difficile vegetative cells and spores can be successfully inactivated using 405nm light, 
the sporicidal efficacy can be significantly enhanced when exposed in the presence of low 
concentration chlorinated disinfectants.  Further research may lead to the potential use of 405nm 
light decontamination in combination with selected hospital disinfectants to enhance C. difficile 
cleaning and infection control procedures.  
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1. Introduction 
Clostridium difficile is a gram positive anaerobe which is the most common cause of antibiotic 
associated diarrhoea, with the spectrum of illness ranging from asymptomatic colonization, to mild 
diarrhoea, to life threatening pseudomembranous colitis [1–3].  The ability of C. difficile to form 
highly infectious and resilient spores which can survive in the environment for prolonged periods 
can result in significant environmental contamination [4,5].  C. difficile is spread by the faecal-oral 
route, however in recent years the environment has been shown to play an important role in the 
spread of disease [6].  Adequate disinfection is of the upmost importance as the rooms of patients 
with C. difficile infection (CDI) can reach contamination rates of up to 50%, whilst those of 
asymptomatic patients can reach approximately 25% contamination, with spores surviving in the 
environment for up to five months [7,8].  The surfaces most frequently contaminated with spores 
are the floors, bathroom areas and the toilet [7–9].  A study carried out by Barbut et al [9] reported 
that 74% of rooms that had housed patients with CDI were contaminated with C. difficile spores.  
Furthermore, a 12% increase in risk of nosocomial CDI was reported when patients were in the 
immediate vicinity, or later occupants, of a room occupied by a patient with CDI [10,11].  
Despite the development of a range of novel disinfection and sterilisation technologies, C. difficile 
remains a significant problem within the environment of various healthcare settings.  Current 
guidelines recommend the use of chlorinated disinfectants for the decontamination of surfaces [12]. 
There are many drawbacks associated with the current decontamination methods used to disinfect 
the rooms of patients diagnosed with C. difficile, with C. difficile remaining in the environment upon 
admission of subsequent patients; samples collected from rooms of patients who are neither 
infected nor colonized with C. difficile have been reported to reach up to 8% contamination, 
demonstrating the inefficiency of currently used disinfectants at eliminating C. difficile [9].  
Furthermore, although chlorinated disinfectants currently used for the elimination of C. difficile 
spores have been demonstrated to significantly reduce C. difficile contamination rates, drawbacks 
include their corrosive nature and the release of irritating vapours affecting healthcare workers [7]. 
Another problem associated with chlorinated disinfectants is the lack of staff compliance with 
adhering to the correct disinfection methods [6]. 
A recent technology that has been proposed for environmental decontamination applications is the 
use of 405 nm violet-blue light [13–16].  Recent studies carried out in hospital isolation rooms have 
demonstrated the use of this technology for continuous decontamination of occupied environments, 
with reductions in the levels of bacterial contaminants by up to 80%, over and above that achieved 
with standard cleaning and infection control procedures alone [13–16]. Although less germicidal 
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than ultraviolet light, violet-blue light has the advantage that it can be used at levels which provide 
an antimicrobial effect whilst being non-detrimental to exposed individuals, or indeed to mammalian 
cell preparations [17–19]. The antimicrobial mechanism of violet-blue light involves the photo-
excitation of intracellular porphyrin molecules within the exposed organisms, which then stimulates 
the production of a range of reactive oxygen species, including singlet oxygen (1O2), resulting in 
oxidative damage to cellular components, and ultimately cell death [15].  Porphyrin photo-excitation 
occurs with light in the region of 400-420 nm, with peak activity being demonstrated at 405 nm [20–
22].  Recent studies have demonstrated the efficacy of violet-blue light for inactivation of a range of 
pathogenic bacteria, fungi, yeasts, and under certain circumstances, viruses [21,23–25]. Successful 
inactivation of endospore-forming bacteria, (Clostridium, Bacillus) and their dormant spores has 
previously been demonstrated [22], however, results were limited and highlighted the resilience of 
spores to light inactivation, therefore further information relating to the efficacy of 405 nm light 
against spores, and how this efficacy can be enhanced, is required.  
As discussed, standard cleaning procedures against C. difficile involve the use of chlorinated 
disinfectants and as both disinfectants and 405 nm light induce lethal oxidative damage to 
microorganisms, their combined use has the potential to deliver enhanced sporicidal effects.  This 
study firstly determines the susceptibility of C. difficile vegetative cells and spores to 405 nm light, 
and progresses to provide the first evidence of the enhanced sporicidal effects of 405 nm light 
through synergistic action with low concentration chlorinated disinfectants including sodium 
hypochlorite (NaOCl), Actichlor and Tristel. 
 
2. Material and Methods 
2.1 Bacterial Preparation 
The bacterial strain used throughout this study was Clostridium difficile NCTC 11204 (National 
Collection of Type Cultures, Collindale, UK). For storage the bacterial culture was inoculated onto 
Microbank beads and stored at -18C until required.  For preparation of vegetative cells, C. difficile 
was streak-inoculated onto blood agar (BA) plates (Blood Agar Base [Oxoid, UK]; 7% horse blood 
[E&O laboratories, UK]) and incubated at 37C for 18 hours under anaerobic conditions (miniMACS 
Anaerobic Workstation, Don Whitley Scientific UK).  Post-incubation, the cells were washed off the 
plate with phosphate buffered saline (PBS; Oxoid UK) by agitation with an L-shaped spreader.  This 
was then diluted to the desired population for experimental use.  The absence of bacterial 
endospores was confirmed by heat treatment at 80°C for 10 minutes prior to enumeration on BA 
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plates.  For preparation of spores, C. difficile was inoculated into 15 ml Brain Heart Infusion (BHI) 
broth (Oxoid, UK) supplemented with 0.1% L-cysteine (Fisher Scientific, UK), and incubated under 
anaerobic conditions at 37C for 7 days.  Post-incubation, the spore suspension was centrifuged at 
3939 ×g for 10-min and resuspended in PBS.  This suspension was heat treated at 80C for 10-min to 
ensure only spores were present, and then diluted to the desired population for experimental use. 
2.2 405nm light inactivation of bacterial suspensions 
The light source used was a 405 nm light emitting diode (LED) array [PhotonStar Technologies, UK], 
with peak output at approximately 405 nm, and a bandwidth of 14 nm at full-width half-maximum 
(FWHM).  The array was attached to a heat sink and fan, to aid thermal management and prevent 
heat transfer to the exposed samples.  
For exposure of both C. difficile vegetative cells and spores, sample volumes of 2ml bacterial 
suspension were positioned in a sample dish approximately 5 cm directly below the LED array.  
Suspensions were then exposed to 405 nm light at an irradiance of 70 or 225 mWcm-2, for vegetative 
cells and spores, respectively, with irradiance measured using a radiant power meter and 
photodiode detector [LOT Oriel, USA].  Samples were exposed to increasing doses of light, with dose 
calculated as irradiance (mWcm-2) × exposure time (s). Controls were subject to identical conditions, 
but exposed to normal laboratory lighting. 
2.3 405 nm light inactivation of spores in the presence of disinfectants 
The disinfectants used in this study were sodium hypochlorite (NaOCl; Fisher Scientific, UK), 
Actichlor (Ecolab Ltd, UK) and Tristel (Tristel solutions Ltd, UK).  Disinfectants were prepared 
according to the manufacturer’s instructions with subsequent dilutions made as required. Before 
experiments investigating the synergistic activity of disinfectants in combination with 405 nm light 
could be carried out, it was important to firstly establish the disinfectant concentrations which 
would cause a negligible effect on the spores over the maximum exposure period required for 
inactivation of the spores using the 405 nm light alone.  Spores were exposed to a range of 
concentrations of each of the three disinfectants and their inactivation effects recorded (Table 1).  
Based on these results, concentrations of 0.0001%, 0.001% and 0.1% were chosen for Tristel, 
Actichlor and sodium hypochlorite, respectively.  Spores were then suspended in these selected 
disinfectant concentrations, and exposed to increasing doses of 405 nm light, at an irradiance of 
225 mWcm-2, as described in Section 2.2.  Controls were subject to identical conditions, but exposed 
to normal laboratory lighting. 
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Table 1.  Exposure of C. difficile spores to chlorinated disinfectants, at a range of concentrations, over 
a 3 hour period. 
Disinfectant Concentration Initial Spore Count 
(log10 CFUml
-1 ± SD) 
Surviving Spore Count 
(log10 CFUml
-1 ± SD) 
% Inactivation 
Sodium 
hypochlorite 
 
0.01% 3.28 ± 0.37 3.25± 0.41 0.9% 
0.1% 3.91 ± 0.13 3.76 ± 0.19 3.8% 
0.2% 2.90 ± 0.33 1.02 ± 1.03 64.8% 
Actichlor 
 
0.001% 3.18 ± 0.35 3.23 ± 0.26 0.0% 
0.01% 2.93 ± 0.38 0.00 ± 0.00 100.0% 
Tristel 
 
0.0001% 3.36 ± 0.08 3.34 ± 0.18 0.59% 
0.001% 3.14 ± 0.21 2.67 ± 0.14 15.0% 
0.01% 2.28 ± 0.28 0.00 ± 0.00 100.0% 
 
2.4 Plating and enumeration 
Post-exposure, samples were spread plated onto BA plates and incubated at 37C for 48 hours under 
anaerobic conditions.  Plates were then enumerated, and results reported as colony forming units 
per millilitre (CFUml-1) as a function of dose (Jcm-2).  Experimental data are an average of a minimum 
of triplicate independent experimental results, measured in duplicate (n≥6), with error bars 
representing the standard deviation (SD). Data were analysed using one-way analysis of variance 
(ANOVA) using Minitab statistical software Version 15, with significant differences accepted at 
P≤0.05. 
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3. Results and Discussion 
3.1 Determination of the susceptibility of C. difficile vegetative cells and spores 
Exposure of C. difficile vegetative cells to 405 nm light demonstrated that cells were susceptible to 
inactivation.  As shown in Figure 1, the population remained fairly constant with doses of up to 
105 Jcm-2, and after which significant inactivation was observed, with a 1.45 log10 reduction after 
exposure to 189 Jcm-2 (P=0.006), and complete inactivation (99.9% reduction) of the 3.3 log10 
population achieved after exposure to 252 Jcm-2 (P=0.000).  
Figure 2 shows the comparative results for the inactivation of spores.  Inactivation was achieved, but 
as expected, the spores proved to be significantly more resilient to light treatment, with 
approximately ten times the dose required to achieve a similar 3.5 log10 reduction as that achieved 
with the vegetative cells.  Inactivation kinetics showed a significant 0.5 log10 reduction after a dose of 
810 Jcm-2 (P=0.001), and 3.3 log10 reduction after 2.43 kJcm
-2 (P=0.000).   
These results demonstrated that C. difficile spores were much more resilient than vegetative cells to 
405 nm-light exposure. A 99.9% reduction in vegetative cell population was demonstrated with a 
dose of 252Jcm-2, whereas, as previously mentioned, spore inactivation required a 10-fold increase 
in dose. These findings support a previous study which reported that C. difficile spores required 
much higher dose levels than vegetative cells to achieve a similar reduction in population [22].  
The significant difference in dose required for inactivation of spores compared to that of vegetative 
cells is expected as spores are resilient, difficult to inactivate structures, developed under stressful 
environmental conditions, and formed to enable bacteria to survive until suitable conditions (such as 
transfer to the human body) return.  This increased resilience of C. difficile spores compared to that 
of vegetative bacteria has also been demonstrated with other decontamination methods, such as 
UV-C. A study by Rutala et al., achieved a >99.9% reduction in vegetative bacterial counts on 
surfaces following a 15 minute exposure to UV-C radiation in comparison to a 99.8% reduction in C. 
difficile spores following a 50 minute exposure to UV-C [26]. In a study carried out by Vohra et al., 
five disinfectants were successful for inhibition of the growth of C. difficile vegetative cells, in 
comparison to spore inactivation in which only Actichlor was found to achieve 3 log10 reduction 
under clean and dirty conditions [27]. Furthermore, It was also the only agent that decontaminated a 
range of non-porous surfaces artificially contaminated with C. difficile spores [27]. This increased 
resilience of spores in comparison to vegetative cells is further supported by a study demonstrating 
that, following induction of spore germination, C. difficile becomes much more susceptible to 
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inactivation by UV-C radiation and heat, due to the restoration of vegetative cell properties and 
irreversible loss of spore properties [28]. 
This enhanced resilience of C. difficile spores in comparison to its vegetative counterpart is similar to 
that of other spore forming bacteria, such as the spores of Bacillus species [29,30]. Bacillus spores 
exhibit an increased resistance to various chemicals that routinely inactivate vegetative cells 
including hydrogen peroxide, alcohols, phenols, chlorhexidine, and benzalkonium compounds 
[29,31,32]. Furthermore, the spores of both Clostridium and Bacillus species have been reported to 
be 5-50 times more resistant than their corresponding vegetative cells to 254 nm UV radiation [33–
35] . 
In comparison to the 3.3 log10 reduction achieved after exposure to 2.4 kJcm
-2 405 nm light in the 
present study, a 1.8-2.9log10 reduction in C. difficile spores was achieved when a population of 10
5 
CFU was inoculated onto stainless steel carrier disks and placed in several areas within a hospital 
room, both in the direct and indirect line of UV-C at a dose of 44.9 – 132 Jcm-2[36]. Nerandzic et al. 
further demonstrated a 2-3 log10 reduction in C. difficile counts following exposure to a constant 
dose of 59.4 Jcm-2 [37].  In a study using a handheld device that generates UV in the far UV spectrum 
(185-230 nm) a 4.4log10 CFU reduction in C. difficile spores, following exposure to 100 mJcm
-2 for 5 
seconds, was reported [38]. Although UV-C is highly successful for the inactivation of C. difficile 
spores, there are several drawbacks associated with the use of UV-C.  These disadvantages include 
exclusion of personnel from treatment zones due to harmful effects of UV-C on the skin and eyes, 
degradation of photosensitive materials, the potential for microbial resistance to develop, and, if 
used intermittently, the decontamination effective is only short term [16].  In comparison with 
ozone, 405 nm light is much more efficient for decontamination. A study comparing the efficacy of 
eight disinfection technologies, including ozone, for decontamination of hospital isolation rooms 
contaminated with C. difficile results demonstrated only a 1.3 log10 reduction following treatment 
with 25 ppm ozone for 142 min [6]. 
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Figure 1.  Inactivation of Clostridium difficile vegetative cells by exposure to 405 nm light.  Cells were 
exposed to an irradiance of 70 mWcm-2, whilst suspended in PBS.  * represent significant bacterial 
inactivation, when compared to the associated non-exposed control (P≤0.05). Each data point is a 
mean value ± SD (n≥6). 
 
Figure 2.  Inactivation of Clostridium difficile spores by exposure to 405 nm light.  Spores were 
exposed to an irradiance of 225 mWcm-2, whilst suspended in PBS.  * represent significant bacterial 
inactivation, when compared to the associated non-exposed control (P≤0.05). Each data point is a 
mean value ± SD (n≥6). 
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3.2 Synergistic sporicidal activity of 405 nm light and disinfectants 
Results demonstrating the synergistic activity of 405 nm light and low concentration chlorinated 
disinfectants are shown in Figures 3-5.  First looking at the control data, C. difficile spores suspended 
in 0.1% NaOCl, 0.001% Actichlor and 0.0001% Tristel alone over the 3-hr period showed no 
significant reduction in population (P=>0.05).  In addition to this, the baseline sporicidal activity of 
405 nm light when the spores were suspended in PBS demonstrated a requirement for doses of 
0.81, 1.62 and 2.43 kJcm-2 to achieve reductions of 0.5,1.3 and 3.5log10 CFUml
-1, respectively.  
Enhanced sporicidal activity was observed in all cases when the spores were exposed to 405 nm light 
whilst suspended in the three disinfectants.  In the case of NaOCl (Figure 3), a significant 1 log10 
reduction was achieved following exposure to a dose of 0.8 kJcm-2  in comparison to a 0.5 log10 
reduction when exposed to 405nm light alone (P=0.007) (Figure 3).  A 3.2log10 reduction was 
achieved following exposure to a dose of 1.62 kJcm-2 in comparison to a 1.3 log10 reduction when 
exposed to 405 nm light alone (Figure 3). When exposed to 405 nm light whilst suspended in 
Actichlor, a significant 1.6 log10 reduction was achieved following exposure to a dose of 0.8 kJcm
-2 in 
comparison to a 0.5 log10 reduction when exposed to 405nm light alone (P=0.001). Near complete 
inactivation (3.2 log10 reduction) was achieved with a dose of 1.62 kJcm
-2, compared to 
approximately 1.5 times this dose being required when using 405 nm light exposure alone (Figure 4).  
Similar results were also shown with Tristel, with a 3.3 log10 reduction observed after exposure to a 
dose of 1.62 kJcm-2 compared to 405 nm light alone, again requiring approximately 1.5 this dose to 
achieve near complete reduction (Figure 5). 
The overall pattern of results achieved in these experiments was fully consistent with the 
demonstration of a synergistic inactivation effect caused by the combined use of 405 nm light and 
the tested chlorinated disinfectants. Whilst the pattern was apparent, and this included statistically 
significant results, not all of the comparative results reached statistical significance and this is most 
likely due to the low population in densities used. Further work will investigate the enhanced 
inactivation of 405nm light in combination with disinfectants against higher population densities. 
 
 
 
11 
 
 
Figure 3.  405 nm light inactivation of Clostridium difficile spores whilst suspended in 0.1% NaOCl.  
Spores were exposed to an irradiance of 225 mWcm-2.  * represent significant bacterial inactivation 
(P≤0.05). Each data point is a mean value ± SD (n=6). 
 
Figure 4.  405 nm light inactivation of Clostridium difficile spores whilst suspended in 0.001% 
Actichlor.  Spores were exposed to an irradiance of 225 mWcm-2.  * represent significant bacterial 
inactivation (P≤0.05). Each data point is a mean value ± SD (n=6). 
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Figure 5.  405 nm light inactivation of Clostridium difficile spores whilst suspended in 0.0001% Tristel.  
Spores were exposed to an irradiance of 225 mWcm-2.  * represent significant bacterial inactivation 
(P≤0.05). Each data point is a mean value ± SD (n=6). 
 
Results of this study demonstrate that the use of 405 nm light in combination with the three 
selected disinfectants can lead to a considerable reduction in exposure time and concentrations of 
disinfectant required to eliminate C. difficile spores.  Results demonstrated that 3-3.5 log10 
reductions could be achieved following exposure to a dose of 1.62 kJcm-2: an approximate 33% 
reduction in dose than that required when using 405 nm light exposure alone.  Significantly, the 
levels of disinfectants that were used were deliberately selected so that they exerted negligible 
effects on the spores when applied alone – thus demonstrating that even low concentration 
disinfectants can induce the synergistic inactivation effect.  Together, the oxidative effects exerted 
by both the disinfectants [39–42] and the 405 nm light exposure [13,21,43] when combined, prove 
to be more lethal than when applied independently, resulting in accelerated spore inactivation. 
An important aspect for consideration in this study is the concentrations of disinfectants used to 
assess the synergistic activity with 405 nm light.  As discussed, the concentrations used were 
selected based on the concentrations that induced no significant effect on the spores over the 
maximum exposure period required to achieve complete inactivation of the C. difficile spores using 
405 nm light alone, i.e. 3-hr (Table 1).  These concentrations proved to be different for each 
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disinfectant (0.1% NaOCl; 0.001% Actichlor; 0.0001% Tristel), and in all cases, were lower than the 
recommended concentrations for use within the clinical environment.  For hospital use, 
concentrations of 0.1% sodium hypochlorite (1,000 ppm available chlorine), 0.1% Actichlor 
(1000 ppm available chlorine), and 0.01% Tristel (100-120 ppm available chlorine) are recommended 
for use [27,41-45]. However, in the case of NaOCl, although a concentration of at least 1,000 ppm is 
currently recommended for high level disinfection, several reports have recommended 
concentrations of 1,000-100,000 ppm for high level disinfection and sporicidal activities [9,46–48] 
and this is likely to be the case with other chlorinated disinfectants.  Although the concentrations 
used in this study were up to 100 times more dilute than recommended for use in the clinical 
environment, when used in combination with 405 nm light significant sporicidal activity was 
achieved. 
This study has established that 405 nm light alone can successfully inactivate C. difficile spores 
(Figure 2), however, the demonstration that sporicidal activity can be enhanced when used in 
combination with hospital disinfectants is of significant interest.  The results presented in this paper 
provide proof-of-concept validation that synergistic sporicidal activity can be achieved using spore 
suspensions and high irradiance levels, however it would be of great interest in future studies to 
replicate the results with contaminated surfaces representative of what would be expected within 
the clinical environment, and lower 405 nm light irradiance levels such as those used for 
environmental decontamination applications [13,14].  A limiting factor of 405 nm light over other 
technologies such as UV-light, hydrogen peroxide vapour or ozone, is the lower sporicidal activity, 
however the ability to enhance this activity through its combined use with disinfectants – which 
would already be in routine use within the hospital environment – coupled with the ability to apply 
this technology safely in the presence of patients and staff [17–19] gives this technology attractive 
features for provision of continuous environmental decontamination against C. difficile. 
In addition to enhancing the sporicidal effects of 405 nm light, the combined use of 405 nm light and 
disinfectants has demonstrated that there is the potential to use lower concentration disinfectants 
whilst still achieving sporicidal activity.  This could have significant advantages due to the recognised 
handling concerns, such as cutaneous and respiratory irritation associated with long term use as well 
as material damage, such as corrosion and pitting on equipment and surfaces, associated with the 
use of high strength chlorinated disinfectants [7,48].    
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4. Conclusions 
In conclusion, this study has demonstrated for the first time that the sporicidal activity of 405 nm 
light against C. difficile can be significantly enhanced when combined with low strength chlorinated 
disinfectants including sodium hypochlorite, Actichlor and Tristel.  Further work is required to 
investigate whether similar synergistic activity can be achieved when spores are seeded on surfaces, 
and whether this effect can be achieved within the clinical environment using irradiance levels 
appropriate for environmental decontamination applications, but the results of this study provide an 
excellent basis for future work in the area.  The results presented suggest that there may be 
potential benefits in using disinfectants in combination with antimicrobial 405 nm light, as together 
they have enhanced sporicidal activity, whilst enabling use of lower concentrations of chlorinated 
disinfectants and thereby reducing potentially harmful effects on both users and materials. Further 
research may lead to the potential use of 405 nm light decontamination in combination with 
hospital disinfectants to enhance C. difficile cleaning and infection control procedures. 
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